Prehospital Lactated Ringer's Solution Treatment and Survival in Out-of-Hospital Cardiac Arrest: A Prospective Cohort Analysis
Background:
No studies have evaluated whether administering intravenous lactated Ringer's (LR) solution to patients with out-of-hospital cardiac arrest (OHCA) improves their outcomes, to our knowledge. Therefore, we examined the association between prehospital use of LR solution and patients' return of spontaneous circulation (ROSC), 1-month survival, and neurological or physical outcomes at 1 month after the event.
Methods and Findings:
We conducted a prospective, non-randomized, observational study using national data of all patients with OHCA from 2005 through 2009 in Japan. We performed a propensity analysis and examined the association between prehospital use of LR solution and short- and long-term survival. The study patients were ≥18 years of age, had an OHCA before arrival of EMS personnel, were treated by EMS personnel, and were then transported to hospitals. A total of 531,854 patients with OHCA met the inclusion criteria. Among propensity-matched patients, compared with those who did not receive pre-hospital intravenous fluids, prehospital use of LR solution was associated with an increased likelihood of ROSC before hospital arrival (odds ratio [OR] adjusted for all covariates [95% CI] = 1.239 [1.146–1.339] [p<0.001], but with a reduced likelihood of 1-month survival with minimal neurological or physical impairment (cerebral performance category 1 or 2, OR adjusted for all covariates [95% CI] = 0.764 [0.589–0.992] [p = 0.04]; and overall performance category 1 or 2, OR adjusted for all covariates [95% CI] = 0.746 [0.573–0.971] [p = 0.03]). There was no association between prehospital use of LR solution and 1-month survival (OR adjusted for all covariates [95% CI] = 0.960 [0.854–1.078]).
Conclusion:
In Japanese patients experiencing OHCA, the prehospital use of LR solution was independently associated with a decreased likelihood of a good functional outcome 1 month after the event, but with an increased likelihood of ROSC before hospital arrival. Prehospital use of LR solution was not associated with 1-month survival. Further study is necessary to verify these findings.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Prehospital Lactated Ringer's Solution Treatment and Survival in Out-of-Hospital Cardiac Arrest: A Prospective Cohort Analysis. PLoS Med 10(2): e32767. doi:10.1371/journal.pmed.1001394
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001394
Souhrn
Background:
No studies have evaluated whether administering intravenous lactated Ringer's (LR) solution to patients with out-of-hospital cardiac arrest (OHCA) improves their outcomes, to our knowledge. Therefore, we examined the association between prehospital use of LR solution and patients' return of spontaneous circulation (ROSC), 1-month survival, and neurological or physical outcomes at 1 month after the event.
Methods and Findings:
We conducted a prospective, non-randomized, observational study using national data of all patients with OHCA from 2005 through 2009 in Japan. We performed a propensity analysis and examined the association between prehospital use of LR solution and short- and long-term survival. The study patients were ≥18 years of age, had an OHCA before arrival of EMS personnel, were treated by EMS personnel, and were then transported to hospitals. A total of 531,854 patients with OHCA met the inclusion criteria. Among propensity-matched patients, compared with those who did not receive pre-hospital intravenous fluids, prehospital use of LR solution was associated with an increased likelihood of ROSC before hospital arrival (odds ratio [OR] adjusted for all covariates [95% CI] = 1.239 [1.146–1.339] [p<0.001], but with a reduced likelihood of 1-month survival with minimal neurological or physical impairment (cerebral performance category 1 or 2, OR adjusted for all covariates [95% CI] = 0.764 [0.589–0.992] [p = 0.04]; and overall performance category 1 or 2, OR adjusted for all covariates [95% CI] = 0.746 [0.573–0.971] [p = 0.03]). There was no association between prehospital use of LR solution and 1-month survival (OR adjusted for all covariates [95% CI] = 0.960 [0.854–1.078]).
Conclusion:
In Japanese patients experiencing OHCA, the prehospital use of LR solution was independently associated with a decreased likelihood of a good functional outcome 1 month after the event, but with an increased likelihood of ROSC before hospital arrival. Prehospital use of LR solution was not associated with 1-month survival. Further study is necessary to verify these findings.
Please see later in the article for the Editors' Summary
Zdroje
1. BulgerEM, MaierRV (2007) Prehospital care of the injured: What's new. Surg Clin North Am 87: 37–53.
2. Emergency Medical Service Technician Law (23 April 1991, number 36). Article 2, paragraph (1)
3. Ministerial Ordinance to Provide for Criteria Pursuant to Emergency Medical Service Technician Law (23 April 1991, number 36). Article 21
4. Guyton AC, Hall JE (2006) Textbook of medical physiology. 5th edition. Philadelphia: Elsevier Saunders. pp. 383–401.
5. MizockBA (1987) Controversies in lactic acidosis. Implications in critically ill patients. JAMA 258: 497–501.
6. KoustovaE, StantonK, GushchinV, AlamHB, StegalkinaS, et al. (2002) Effects of lactated Ringer's solutions on human leukocytes. J Trauma 52: 872–878.
7. JaskilleA, AlamHB, RheeP, HanesW, KirkpatrickJR, et al. (2004) D-lactate increases pulmonary apotosis by restricting phosphorylation of bad Bnd abd eNOS in a rat model of hemorrhagic shock. J Trauma 57: 262–270.
8. MooreFA (2011) The use of lactated Ringer's in shock resuscitation: the good, the bad and the ugly. J Trauma 70: S15–S16.
9. Macintyre N (2006) “Fluid management in patients with ALI from the NIH ARDS Network fluid management trial.” http://www.medscape.com/viewarticle/543504. Accessed 12 December 2011.
10. BeekleyAC, StarnesBW, SebestaJA (2007) Lessons learned from modern military surgery. Surg Clin North Am 87: 157–184.
11. BenderR, BreilM, HeisterU, DahmenA, HoeftA, et al. (2007) Hypertonic saline during CPR: feasibility and safety of a new protocol of fluid management during resuscitation. Resuscitation 72: 74–81.
12. BruelC, ParientiJJ, MarieW, ArrotX, DaubinC, et al. (2008) Mild hypothermia during advanced life support: a preliminary study in out-of-hospital cardiac arrest. Crit Care 12: R31.
13. DitcheyRV, LindenfeldJ (1984) Potential adverse effects of volume loading on perfusion of vital organs during closed-chest resuscitation. Circulation 69: 181–189.
14. VoorheesWD, RalstonSH, KougiasC, SchmitzPM (1987) Fluid loading with whole blood or Ringer's lactate solution during CPR in dogs. Resuscitation 15: 113–123.
15. FischerM, DahmenA, StandopJ, HagendorffA, HoeftA, et al. (2002) Effects of hypertonic saline on myocardial blood flow in a porcine model of prolonged cardiac arrest. Resuscitation 54: 269–280.
16. JoffeMM, RosenbaumPR (1999) Invited commentary: propensity scores. Am J Epidemiol 150: 327–333.
17. KitamuraT, IwamiT, KawamuraT, NagaoK, TanakaH, et al. (2010) Nationwide public-access defibrillation in Japan. N Engl J Med 362: 994–1004.
18. HagiharaA, HasegawaM, AbeT, WakataY, NagataT, et al. (2012) Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. JAMA 307: 1161–1168.
19. Japan Resuscitation Council, and Japan Foundation for Emergency Medicine. (Editorial Supervision) (2007) Japanese guidelines for emergency care and cardiopulmonary resuscitation. 3rd edition. Tokyo: Health Shuppansha.
20. The Fire and Disaster Management Agency (FDMA) (2006) Guidelines for the resuscitation by emergency lifesaving technicians. (14 February 2006). Tokyo: The Fire and Disaster Management Agency (FDMA) instructions number 1.
21. (1948) Medical Practitioner's Law, 30 July 1948, law number 201.
22. CumminsRO, ChamberlainDA, AbramsonNS, AllenM, BaskettPJ, et al. (1991) Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein style- a statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation 84: 960–75.
23. Ministry of Health, Labour and Welfare (2010) Various information of medical fee. http://www.iryohoken.go.jp/shinryohoshu/. Accessed 1 March 2012.
24. KurokiY, IkedaT, IkedaK, MukojimaK, YokoyamaT, et al. (2007) One-way association between arterial lactate concentration and ROSC among patients with OHCA [in Japanese]. Journal of Japanese Society for Emergency Medicine 10: 393–396.
25. JacobsI, NadkarniV, BahrJ, BergRA, BilliJE, et al. (2004) Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein template for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation. Circulation 110: 3385–3397.
26. Parsons LS, Ovation Research Group, Seattle. SUGI 26: Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Available: http://www2.sas.com/proceedings/sugi26/p214-26.pdf#search=‘propensity score, sas’. Accessed 10 February 2012
27. HsiehFT, BlockDA, LarsenMD (1998) A simple method of sample size calculation for linear and logistic regression. Stat Med 17: 1623–1634.
28. ItoN, NantoS, NagaoK, HatanakaT, NishiyamaK, et al. (2011) Regional cerebral oxygen saturation on hospital arrival is a potential novel predictor of neurological outcomes at hospital discharge in patients with out-of-hospital cardiac arrest. Resuscitation 83: 46–50.
29. KimJJ, LimYS, ShinJH, YangHJ, KimJK, et al. (2006) Relative adrenal insufficiency after cardiac arrest: impact on postresuscitation disease outcome. Am J Emerg Med 24: 684–688.
30. AdrogueHJ, MadiasNE (1998) Management of life-threatening acid-base disorders. N Engl J Med 338: 26–34.
31. ShinozakiK, OdaS, SadahiroT, NakamuraM, HirayamaY, et al. (2011) Blood ammonia and lactate levels on hospital arrival as a predictive biomarker in patients with out-of-hospital cardiac arrest. Resuscitation 82: 404–409.
32. BreilM, KrepH, HeisterU, BartschA, BenderR, et al. (2012) Randomised study of hypertonic saline infusion during resuscitation from out-of-hospital cardiac arrest. Resuscitation 83: 347–352.
33. WilliamsEL, HildebrandKL, McCormickSA, BedelMJ (1999) The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 88: 999–1003.
34. BingOH, BrooksWW, MesserJV (1973) Heart muscle viability following hypoxia: protective effect of acidosis. Science 180: 1297–1298.
35. InserteJ, BarbaI, HernandoV, Garcia-DoradoD (2009) Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium. Cardiovasc Res 81: 116–122.
36. BruelC, ParientlJJ, MarieW, ArrotX, DaubinC, et al. (2008) Mild hypothermia during advanced life support: a preliminary atudy in out-of-hospital cardiac arrest. Critical Care 12: R31.
37. KamarainenA, VirkkunenI, TenhunenJ, Yli-HankalaA, SilfvastT (2008) Prehospital induction of therapeutic hypothermia during CPR: a pilot study. Resuscitation 76: 360–363.
38. AltmanDG, BlandJM (2003) Interaction revisited: the difference between two estimates. BMJ 326: 219.
39. HasegawaK, HiraideA, ChangY, BrownDFM (2013) Association of prehospital advanced airway management with neurologic outcome and survival in patients with out-of-hospital cardiac arrest. JAMA 309: 257–266.
40. GrogaardHK, WikL, EriksenM, BrekkeM, SundeK (2007) Continuous mechanical chest compressions during cardiac arrest to facilitate restoration of coronary circulation with percutaneous coronary intervention. J Am Coll Cardiol 50: 1093–1094.
41. VirkkunenI, PaasioL, RyynänenS, VuoriA, SajantilaA, et al. (2008) Pulseless electrical activity and unsuccessful out-of-hospital resuscitation: what is the cause of death? Resuscitation 77: 207–210.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 2
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
- Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
- Whole Genome Sequencing versus Traditional Genotyping for Investigation of a Outbreak: A Longitudinal Molecular Epidemiological Study
- Prevalence of Age-Related Macular Degeneration in Nakuru, Kenya: A Cross-Sectional Population-Based Study